[go: up one dir, main page]

NO169284C - Fremgangsmaate for omdannelse av en polymorf krystallinsk form av buspiron-hydroklorid til dens andre polymorfe krystallinske form - Google Patents

Fremgangsmaate for omdannelse av en polymorf krystallinsk form av buspiron-hydroklorid til dens andre polymorfe krystallinske form

Info

Publication number
NO169284C
NO169284C NO883806A NO883806A NO169284C NO 169284 C NO169284 C NO 169284C NO 883806 A NO883806 A NO 883806A NO 883806 A NO883806 A NO 883806A NO 169284 C NO169284 C NO 169284C
Authority
NO
Norway
Prior art keywords
polymorph
crystallinic
conversion
buspiron
hydrochloride
Prior art date
Application number
NO883806A
Other languages
English (en)
Other versions
NO169284B (no
NO883806L (no
NO883806D0 (no
Inventor
Robert James Behme
Terry Tim Kensler
Douglas Gene Mikolasek
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO883806D0 publication Critical patent/NO883806D0/no
Publication of NO883806L publication Critical patent/NO883806L/no
Publication of NO169284B publication Critical patent/NO169284B/no
Publication of NO169284C publication Critical patent/NO169284C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Arrangement Or Mounting Of Propulsion Units For Vehicles (AREA)
  • Body Structure For Vehicles (AREA)
  • Glass Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Gears, Cams (AREA)
NO883806A 1987-08-28 1988-08-25 Fremgangsmaate for omdannelse av en polymorf krystallinsk form av buspiron-hydroklorid til dens andre polymorfe krystallinske form NO169284C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/090,302 US4810789A (en) 1987-08-28 1987-08-28 Process for buspirone hydrochloride polymorphic crystalline form conversion

Publications (4)

Publication Number Publication Date
NO883806D0 NO883806D0 (no) 1988-08-25
NO883806L NO883806L (no) 1989-03-01
NO169284B NO169284B (no) 1992-02-24
NO169284C true NO169284C (no) 1992-06-03

Family

ID=22222189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883806A NO169284C (no) 1987-08-28 1988-08-25 Fremgangsmaate for omdannelse av en polymorf krystallinsk form av buspiron-hydroklorid til dens andre polymorfe krystallinske form

Country Status (23)

Country Link
US (1) US4810789A (no)
EP (1) EP0304940B1 (no)
JP (1) JP2702519B2 (no)
KR (1) KR970011294B1 (no)
AT (1) ATE113044T1 (no)
AU (1) AU618746B2 (no)
CY (1) CY1839A (no)
DE (1) DE3851865T2 (no)
DK (1) DK478688A (no)
ES (1) ES2060632T3 (no)
FI (1) FI91066C (no)
HK (1) HK71495A (no)
HU (1) HU199831B (no)
IE (1) IE65988B1 (no)
IL (1) IL87292A (no)
MY (1) MY100863A (no)
NO (1) NO169284C (no)
NZ (1) NZ225895A (no)
OA (1) OA08907A (no)
PT (1) PT88355B (no)
SU (1) SU1731056A3 (no)
YU (1) YU46961B (no)
ZA (1) ZA885867B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
HU217129B (hu) * 1993-07-16 1999-11-29 EGIS Gyógyszergyár Rt. Eljárás nagy tisztaságú buspiron gyógyászati hatóanyag előállítására
ATE212337T1 (de) * 1993-11-09 2002-02-15 Syngenta Participations Ag Kristallmodifikation von (4-cyclopropyl-6-methyl- pyrimidin-2-yl)- phenyl-amin, und verfahren zu dessen herstellung
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
KR100322018B1 (ko) * 1999-01-23 2002-02-04 윤종용 음성대역 잡음 보상장치
US6465255B1 (en) * 1999-01-29 2002-10-15 The Regents Of The University Of California Method for identifying and probing phase transitions in materials
DK1505066T3 (da) * 2002-04-19 2007-03-19 Faes Farma Sa Polymorf af 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-IL]-1-piperidinyl]ethyl]-alfa,alfa-dimethylbenzeneddikesyre
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa 4−[2−[1−(2−エトキシエチル)−1H−ベンズイミダゾール−2−イル]−1−ピペリジニル]エチル]−α,α−ジメチルベンゼノ酢酸の多形体
CN118702676B (zh) * 2024-07-09 2026-01-27 济南大学 一种盐酸丁螺环酮晶型ii的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4351939A (en) * 1980-10-16 1982-09-28 Mead Johnson & Company Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
DD263531A5 (de) * 1986-10-21 1989-01-04 ������@���Kk�� Verfahren zur herstellung von verbrueckten bicyclischen imidverbindungen
US5015646A (en) * 1987-08-28 1991-05-14 Bristol-Myers Squibb Co. Pharmaceutically useful polymorphic modification of buspirone

Also Published As

Publication number Publication date
IL87292A (en) 1992-07-15
IE882362L (en) 1989-02-28
IE65988B1 (en) 1995-11-29
HUT47563A (en) 1989-03-28
IL87292A0 (en) 1989-01-31
PT88355B (pt) 1995-12-29
PT88355A (pt) 1989-06-30
EP0304940A1 (en) 1989-03-01
OA08907A (en) 1989-10-31
FI883960L (fi) 1989-03-01
AU2048088A (en) 1989-03-02
US4810789A (en) 1989-03-07
KR970011294B1 (ko) 1997-07-09
HU199831B (en) 1990-03-28
NZ225895A (en) 1991-04-26
YU160488A (en) 1990-04-30
ZA885867B (en) 1989-05-30
JPS6471872A (en) 1989-03-16
KR890003739A (ko) 1989-04-17
AU618746B2 (en) 1992-01-09
NO169284B (no) 1992-02-24
MY100863A (en) 1991-03-15
YU46961B (sh) 1994-09-09
JP2702519B2 (ja) 1998-01-21
FI91066C (fi) 1994-05-10
FI883960A0 (fi) 1988-08-26
DE3851865D1 (de) 1994-11-24
NO883806L (no) 1989-03-01
DK478688D0 (da) 1988-08-26
FI91066B (fi) 1994-01-31
DK478688A (da) 1989-03-01
EP0304940B1 (en) 1994-10-19
HK71495A (en) 1995-05-19
NO883806D0 (no) 1988-08-25
SU1731056A3 (ru) 1992-04-30
CY1839A (en) 1995-12-01
ATE113044T1 (de) 1994-11-15
DE3851865T2 (de) 1995-02-23
ES2060632T3 (es) 1994-12-01

Similar Documents

Publication Publication Date Title
NO169284C (no) Fremgangsmaate for omdannelse av en polymorf krystallinsk form av buspiron-hydroklorid til dens andre polymorfe krystallinske form
HUT45984A (en) Process for production of quinoline-derivatives and of their medically acceptable acid-additioned salts
GEP19970818B (en) Method of n-/2-/4-fluorphenyl/-1-methyl/-ethyl-n-methyl-n-propinylamine production
PL268034A1 (en) The method of manufacture of new 7-phenylglycil-1-carbo-destiacephalosphorines
NO883805D0 (no) Polymorf variant av forbindelsen 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro-(4.5)dekan-7,9-dion.
FR2445318A1 (fr) Procede de preparation de 1-(3-mercapto-propanoyl)-l-prolines
ID964B (id) SENYAWA 4-(5,6,7,8-TETRAHIDROIMIDAZO[1,5-a]PIRIDIN-5-IL)HEMIHIDRAT
SE8501679L (sv) Stereokontrollerat acetoxiazetidinon-forfarande
SE8203580L (sv) Sett att framstella apovinkaminsyraestrar
DK133083A (da) Fremgangsmaade til fremstilling af phenylalkyloxirancarboxylsyrer
FR2575472B1 (fr) Procede de preparation d'hydrogeno- ou d'halogenosilanes
RO87706A (ro) Procedeu pentru prepararea nizatidinei
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA
SE8701861L (sv) Forfarande for framstellning av kondenserade ac-triaziniumderivat
FR2595693B1 (fr) Procede de fabrication de dialcoxy-4,4 butene-2 oate d'alkyle